Article
Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.
Journal of immunology (Baltimore, Md. : 1950) - 15 Mar 2008
Moesta Achim K, Norman Paul J, Yawata Makoto, Yawata Nobuyo, Gleimer Michael, Parham Peter
Abstract excerpt
Interactions between HLA-C ligands and inhibitory killer cell Ig-like receptors (KIR) control the development and response of human NK cells. This regulatory mechanism is usually described by mutually exclusive interactions of KIR2DL1 with C2 having lysine 80, and KIR2DL2/3 with C1 having asparagine 80. Consistent with this simple rule, we found from functional analysis and binding assays to 93 HLA-A, HLA-B, and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
